ASAlena V. Svarval

Alena V. Svarval

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alena V. Svarval has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Helicobacter pylori in Russian children: a multidimensional cross-sectional study

    by Daria Starkova, Nikita Gladyshev, Andrey Komissarov, Anna Ivanova, Anton Buchaka, Konstantin Ermolenko, Natalia Parolova, Ulker Babaeva, Evdokiya Nikolaeva, Ludmila Suzhaeva, et al.

  • Herd immunity to diphtheria in the population of several russian regions

    by A. Yu. Popova, V. S. Smirnov, S. A. Egorova, L. V. Buts, A. M. Milichkina, V. A. Ivanov, E. M. Danilova, O. B. Zhimbaeva, V. G. Drobyshevskaya, O. V. Kotsar, et al.

    Diphtheria is a serious infection, often characterized by a pronounced toxic component, which can be accompanied by severe complications of the cardiovascular and nervous systems. The primary method of infection prevention is immunization (primarily in children) with diphtheria toxoid, which induces effective and long-lasting antitoxic immunity. Objective of the study: evaluation of collective immunity to the causative agent of diphtheria among the population of several regions (Amur, Irkutsk, Nizhny Novgorod, Kaliningrad) and the Republic of Crimea. Materials and methods. The cross-sectional cohort randomized study involved 18,207 people uniformly stratified by age (1–5, 6–11, 12–17, 18–29, 30–39, 40–49, 50–59, 60–69, 70+ years), including: 3,576 in Amur; 3,657 in Irkutsk; 3,580 in Nizhny Novgorod; 3,613 in Kaliningrad regions; and 3,781 in the Republic of Crimea. All studies were conducted in strict accordance with the requirements of the Declaration of Helsinki. Immunoglobulin G Abs to the C. diphtheriae toxin were determined in the examined volunteers by enzyme immunoassay using a Russian-made test system. Data analysis and statistical processing were carried out using a web application. Results. The average cohort regional seroprevalence levels were: Amur Region - 82.3% (95% CI: 81.0 - 83.5); Irkutsk - 87.6% (95% CI: 87.6-88.9); Nizhny Novgorod - 86.5% (85.3-87.6); Kaliningrad - 74.2% (95% CI: 72.8 - 75.6); and the Republic of Crimea - 74.8% (95% CI: 73.4-76.1). In some cases, seropositivity did not reach 60%, namely: among individuals aged ≥60 in the Kaliningrad Region and the Republic of Crimea; and among individuals aged ≥70 in the Amur and Nizhny Novgorod Regions. Most volunteers had serum IgG Abs to diphtheria toxin at concentrations of 0.1–1.0 IU/ml, regardless of age, region, or vaccine type. Conclusion. The level of collective immunity mandated by current Russian documents (95% in children, 90% in adults) was practically not achieved in any region or age group (except children aged 1–5 years in the Irkutsk and Nizhny Novgorod Regions). In all regions, the least protected group were individuals aged 60 and older, among whom the seronegative value reached 30–45%.

  • Open Access

    Herd immunity to measles, rubella, and mumps in several Russian regions

    by Anna Yu. Popova, Vyacheslav S. Smirnov, Svetlana A. Egorova, Lidiya V. Buts, Angelika M. Milichkina, Valery A. Ivanov, Ekatherina M. Danilova, Oyuna B. Zhimbaeva, Victoria G. Drobyshevskaya, Oleg V. Kotsar, et al.

    Introduction. Mass vaccination, implemented in Russia within the framework of the Russia National Vaccination Calendar, is a key component in the fight against vaccine-preventable infections (measles, mumps, rubella). The aim. The study’s aim was to assess herd immunity to the most common vaccine-preventable infections in several Russian regions. Materials and methods. The study involved 18 247 volunteers from several regions (Amur, Irkutsk, Nizhny Novgorod, Kaliningrad) and the Republic of Crimea. During the study, participants completed a questionnaire. A cohort of volunteers, stratified by age (1–5, 6–11, 12–17, 18–29, 30–39, 40–49, 50–59, 60–69, ≥ 70 years), was randomized using a web application. Antibodies to the measles, rubella, mumps were quantitated by ELISA (IgG) using Russian-made test systems. Results. The cohort average seropositivity magnitude for measles, mumps, and rubella were 75.7%, 84.0%, and 95.8%, respectively. For measles, the highest seropositivity level was observed in the group 1–11 years (Me = 74.8%; IQR = 68.5–83.5) and the group 60–70+ years (95.1%; IQR = = 93.2–95.8). Regarding mumps, these two ago groups also showed peak values: 1–11 years (Me = 85.9%; IQR = 81.4–92.5) and 60–70+ years (Me = 88.6%; IQR = 83.7–90.6). The lowest measles seroprevalence was observed in 18–39-year age group (Me = 59.7%; IQR = 55.9–64.6). For mumps, the lowest seroprevalence was also observed in 18–39-year age group (Me = 78.4%; IQR = 63.9–83.7). Regarding rubella, seropositivity was evenly distributed across the entire cohort: Me = 95.8% (IQR = 93.9–97.5). Among specific vaccines for immunization against measles/mumps or rubella, the mumps-measles or live monovalent rubella vaccine, respectively, was most or more frequently used. Conclusion. High measles and mumps seroprevalence among children is due to post-vaccination immunity following mass immunization, primarily with the mumps-measles vaccine. Seroprevalence in older adults is associated with childhood infections that have elicited post-infectious immunity. Rubella immunity was virtually independent of age, geographic location, or climate factors. Reduced measles and mumps seropositivity among middle-aged individuals may lead to emergence of sporadic cases of these diseases, which may require additional measures, including catch-up vaccination.

  • Open Access

    A diagnostic algorithm for Helicobacter pylori detection and identification in gastric mucosal biopsies

    by Alena V. Svarval, D. A. Starkova, L. A. Kaftyreva

    Helicobacter pylori is a major etiological agent in gastritis, peptic ulcer disease, gastric adenocarcinoma, and MALT lymphoma. While gastric mucosal biopsies are the primary material for invasive diagnosis, a comprehensive diagnostic approach is needed. This study presents a diagnostic algorithm that facilitates not only H. pylori detection and identification but also, when necessary, the subsequent analysis of isolated microbial strains, e.g., virulence gene determinants or antibiotic resistance mutations. Having applied this algorithm from 2013 to 2024, we examined gastric biopsies from 610 patients (57% female, 43% male) aged 19–73 years with various gastrointestinal pathologies using culture and molecular methods. In our study, H. pylori detection rate by PCR vs culture examination (48.20% vs 32.3% respectively) in gastric biopsies was significantly higher. In gastric cancer, H. pylori DNA detection rate was minimal and amounted to 35.7%, which correlated with the lowest culture-based isolation rate (9.5%). Since vacA virulence gene is presented in all H. pylori strains, it was used as a marker for H. pylori detection in our study. Thus, the vacA gene was detected in 48.0% (258/537) biopsy samples. The cagA gene is not presented in all H. pylori strains and considered to be a high virulence marker. In addition, it was found out that the cagA gene was present in 47.3% H. pylori-positive cases. Notably, the proportion of cagA-positive isolates turned out to be minimal in chronic gastritis — 39.4%, in contrast to its level in peptic ulcer and gastric cancer comprising 77.3% (p 0.001) and 72.7% (p = 0.029), respectively. Conclusion. The proposed diagnostic algorithm is applicable in microbiological practice for diagnosis, epidemiological monitoring, and research in H. pylori infections.

  • Open Access

    Determinants of resistance to levofloxacin and metronidazole in Russian clinical isolates of Helicobacter pylori based on whole-genome sequencing data

    by Daria А. Starkova, Nikita S. Gladyshev, Dmitrii E. Polev, Alina Т. Saitova, Ksenia А. Glazunova, Svetlana А. Egorova, Alena V. Svarval

    Introduction. Helicobacter pylori infection, however, data on the mechanisms of metronidazole (MTZ) and levofloxacin (LVX) resistance in Russia remain scarce. and levofloxacin (LVX) in Russia. The aim of the study is to identify the determinants of resistance in clinical isolates of H. pylori to MTZ and LVX using whole-genome sequencing data. Materials and methods. A retrospective analysis of 43 H. pylori isolates obtained from adult patients (2014–2022) was conducted. Susceptibility to antibiotics was determined using the bacteriological disk diffusion method. Whole-genome sequencing of 43 H. pylori strains was performed using a DNBSEQ-G50 sequencer. Results. The evaluation of the phenotypic drug susceptibility test results showed that 11 isolates were susceptible to MTZ (MTZ-S), 31 were susceptible to LVX (LVX-S), while 32 isolates were resistant to MTZ (MTZ-R), and 12 were resistant to LVX (LVX-R). To identify the association between phenotypic and genotypic resistance, an analysis of nucleotide substitutions in the gyrA, gyrB, rdxA, frxA, fdxB and fur genes was conducted. Of all the mutations identified in the gyrA and gyrB genes, only D91/GNY in the gyrA gene was associated with phenotypic resistance to LVX and was found in 4/12 (33.3%) of the isolates (p 0.05). The combined mutation D91G/N/Y+N87K in the gyrA gene was detected in 6/12 (50.0%) of LVX-R isolates (p 0.001). Point mutations in the rdxA gene were detected in 21.9% (7/32) of MTZ-R isolates, leading to a frameshift or premature termination of protein synthesis. None of the mutations in the frxA, fur and fdxB genes were associated with H. pylori resistance to MTZ. Conclusion. Based on the results of whole-genome sequencing of Russian clinical isolates of H. pylori, the detection of the combined mutation D91G/N/Y+N87K in the gyrA gene can serve as a predictor of the phenotypic resistance of H. pylori to levofloxacin.

  • Open Access

    First insight into the whole genome sequence variations in clarithromycin resistant Helicobacter pylori clinical isolates in Russia

    by Daria Starkova, Nikita Gladyshev, Dmitrii Polev, Alina Saitova, Svetlana Egorova, Alena Svarval

    Clarithromycin (CLR) is currently a key antibiotic for Helicobacter pylori infection treatment, however, the data on CLR resistance patterns in Russia are missing. Here, we applied WGS-based approach to H. pylori clinical isolates from Russia to comprehensively investigate sequence variation, identify putative markers of CLR resistance and correlate them with phenotypic susceptibility testing. The phenotypic susceptibility of 44 H. pylori isolates (2014–2022) to CLR was determined by disc diffusion method: 23 isolates were CLR-resistant and 21-CLR-susceptible. All isolates were subjected to WGS and submitted to GenBank. Based on complete sequence analysis, we showed that among all sequence variants, the combination of mutations A2146G/A2147G in the 23S rRNA gene is the most reliable for prediction of phenotypic susceptibility. For the first time, the average number of mutations in 106 virulence-associated genes between resistant and susceptible groups were compared. Moreover, this study presents the first WGS insight into genetic diversity of H. pylori in Russia with a particular focus on the molecular basis of drug resistance: the novel mutations were described as potential markers for the resistance development. Of these, the most prominent was a frameshift deletion (252:CGGGT) in HP0820 coding region, which is a good candidate for further investigation.


  • Open Access

    Semi-quantitative assessment of Helicobacter pylori by rapid urease tests in pediatrics

    by E. A. Kornienko, E. O. Kolomina, N. I. Parolova, S. S. Ermakov, U. M. Babaeva, N. S. Gladyshev, А. В. Сварваль, E. E. Shchederkina

    The study is devoted to the comparison of the results of rapid urease tests (RUT) and the data obtained in histological examination. For this purpose, the semi-quantitative assessment of urease activity of two BUTs was compared: the semi-quantitative Pronto Dry (GASTREX, France) widely used in Europe and the AMA RUT Expert M test registered in Russia (AMA LLC, Russia) with the data obtained by histological and PCR analyses. High correlation of semi-quantitative indices of urease activity according to the results of both tests as well as correlation of these indices with the data obtained by histological examination and PCR analysis was established.


  • Open Access

    Virulence determinants and genotypes of Helicobacter pylori clinical isolates

    by Alena V. Svarval, Daria A. Starkova, Raisa S. Ferman

    Background. H. pylori is the principal causative agent of gastroduodenal disorders in humans. The development and severity of lesions in infected individuals depend on the virulence of H. pylori strains. Aims: Detection of virulence determinants and comparative analysis of H. pylori genotypes in patients with chronic gastritis (CG) and duodenal ulcer (DU). Materials and methods. The 53 H. pylori strains were isolated in St. Petersburg from patients with CG (n = 34) and DU (n = 19). The genetic determinants of virulence cagA, iceA, vacA and H. pylori genotypes in patients with CG and UC were determined using the standard PCR method. Results. The cagA gene was found in 64.1% of H. pylori strains. The proportions of cagA+ isolates from patients with CG and DU was 55.8% (15/34) and 78.9% (15/19), respectively (p 0.05). The iceA1 allele of H. pylori was detected in 47.4% of patients with DU, the iceA2 in 47.1% of patients with CG (p 0.05). The vacAs1 allele was significantly dominant in patients with DU 94.7% versus 70.6% in CG (p 0.05). No significant difference in vacA m1 and m2 alleles was found in H. pylori from different groups of patients (p 0.05). All cagA+ strains were carriers of the vacA s1 allele. The vast majority of strains (10 out of 11) of the cagA/vacAs2 genotype were isolated from patients with CG. Conclusion. The significant association between vacAs1, vacAs2 allelic variants, as well as vacA s1/m2, vacA s2/m2 genotypes of the pathogen and severity of clinical manifestations of H. pylori infection has been established in our study. The vacAs1 and vacA s1/m2 genotypes of the pathogen are associated with duodenal ulcer.


  • Open Access

    Phylogenetic structure of the global population of Helicobacter Pylori

    by Daria A. Starkova, A. V. Svarval

    Helicobacter pylori (H. pylori) is widely considered to be one of the oldest bacteria in the human microbiome. During the co-evolutionary relationships between humans and H. pylori bacterium, spanning at least 100 000 years, a high rate of mutation and recombination events led to extremely high genomic polymorphism of the H. pylori species. Despite this, the large diversity of H. pylori genomes is very well structured, allowing to divide it into different populations associated with the geographic location of H. pylori strains. To date, seven modern H. pylori populations have been determined globally: hpAfrica1, hpAfrica2, hpEastAsia, hpEurope, hpAsia2, hpNEAfrica and hspSahul originated from at least six ancestral populations (ancestral European 1, ancestral European 2, ancestral EastAsia, ancestral Africa1, ancestral Africa2, ancestral Sahul). The global phylogenetic analysis showed that H. pylori is organized into two superlineages: one containing hpAfrica2 and the other containing all other populations in a single monophyletic clade. This indicates that, hpAfrica2 is the most ancient of all H. pylori populations, while the others continued evolutionary development along as mankind spread beyond the African continent. Thus, the H. pylori species populational diversification, which occurred in parallel with paired hosts, allowed us to use H. pylori genetic variants as biological markers, reflecting ethnogeographic migration processes in human history. Moreover, the rapid and dynamic evolution of H. pylori informs about ongoing recombination events enabling use H. pylori as a model both for the co-evolution of pathogenic bacteria and humans as well as for within-individual host pathogen microevolution. This review summarized developments from numerous studies on coevolution process and phylogenetic pattern of the global H. pylori population. The relationships between currently known bacterial populations and subpopulations, related geographical distribution, reconstruction of evolutionary pathway for ancestral and recent populations are detailed. New data on the H. pylori strain populational pattern in Russia, as well as strains circulating in the Northern, Central and South America, are presented. Phylogenetic analysis of the H. pylori population pattern permitted to reconstruct both prehistoric and recent human migrations, demographic processes as well as multilayered evolutionary pathways of H. pylori population.

  • Open Access

    The clinical effectiveness of probiotics and autoprobiotics in treatment of Helicobacter pylori-associated dyspepsia

    by Elena I. Ermolenko, Anastasiya S. Molostova, Natalia V. Baryshnikova, Alena V. Svarval, Nikita S. Gladyshev, Victor A. Kashchenko, Alexander N. Suvorov, Кащенко Виктор Анатольевич

    The aim of our study was to evaluate the clinical performance of a monotherapy by Enterococcus faecium-based probiotics and indigenous autoprobiotics against H. pylori associated dyspepsia. Materials and methods. There were examined 95 patients with dyspepsia. The entire patient cohort underwent clinical evaluation including filling out the questionnaire to assess dyspepsia symptoms before and after treatment, gastric endoscopy as well as gastric multi-focal biopsy (gastric body and gastric antrum) and verification of H. pylori infection with the three clinical laboratory methods (biochemical, bacteriological and molecular detection). An antagonistic in vitro activity of probiotics against H. pylori was detected by drop plate method for probiotic strains Enterococcus faecium SF68 and Bifidobacterium bifidum (Bifiform), Enterococcus faecium L3 (Laminolact), and autoprobiotic strains combined with indigenous Enterococcus faecium. To examine an antagonistic activity of probiotics and autoprobiotics in clinical trials, we used a starter culture based on the Enterococcus faecium L3 strain and an autoprobiotic based on indigenous Enterococcus faecium. The probiotic or autoprobiotic were administered orally to patients with gastritis twice a day at dose of 50 ml (8.0 lgCFU/ml) for 20 days. H. pylori eradication was assessed by stool antigen test 1.52 months after the end of treatment. Results. Initially the H. pylori infection was confirmed with 49.4% of patients. The sensitivity of H. pylori to the probiotics was detected in 81% of individuals for indigenous Enterococci (the autoprobiotic), 76% for Laminolact, and in 62% for Bifiform. 22 patients with previous history of allergic reactions to antibiotics used in routine H. pylori eradication regimens were divided in two cohorts. One cohort (10 patients) received the autoprobiotic only, another cohort (12 patients) received only probiotic. Monotherapy with autoprobiotic resulted in 100% H. pylori eradication, single-agent therapy with probiotic led to 60% eradication of H. pylori. Dyspepsia symptoms were completely resolved in both groups of patients. Conclusion. Our research demonstrated the sensitivity of examined H. pylori strains to be similar for traditional eradication treatment agents (antibiotics) and the proposed intervention agents (probiotics and autoprobiotics). An autoprobiotic monotherapy with indigenous enterococci led to higher levels of H. pylori eradication than with E. faecium L3-based probiotic agent. Our work demonstrated advantage for application of probiotics in patients with antibiotic allergies or other obstacles for the standard eradication therapy. Nonetheless, further investigation to better understand underlying mechanisms of action, as well as larger observational and randomized studies, are necessary to determine the scope of therapeutic application for probiotics and autoprobitics to eradicate H. pylori infection.